BTC health (ASX: $BTC) exclusive distribution agreement with Wexler Surgical

BTC health Ltd (ASX: $BTC) has announced that its investee company, BTC Cardio Pty Ltd, has secured an exclusive distribution agreement with Wexler Surgical, Inc. The agreement grants BTC Cardio exclusive sales and distribution rights for Wexler's high-quality range of cardiothoracic, vascular, minimally invasive, and pediatric surgical instruments in Australia and New Zealand. The products, previously distributed by Advanced Biomedical, are TGA approved and will be transferred to BTC Cardio effective from 18 May 2024.

Executive Commentary on Exclusive Distribution Agreement

Dr Richard Treagus, Executive Chairman of BTC health, expressed his delight in partnering with Wexler and representing their products in the region. He emphasized that the Wexler range is a strong complementary fit with their expanding cardiothoracic product portfolio.

Summary of Exclusive Distribution Agreement

BTC health (ASX: $BTC) has secured an exclusive distribution agreement with Wexler Surgical, Inc, granting its investee company, BTC Cardio Pty Ltd, exclusive sales and distribution rights for Wexler's high-quality surgical instruments in Australia and New Zealand. The TGA-approved products, previously distributed by Advanced Biomedical, will be transferred to BTC Cardio effective from 18 May 2024. Dr Richard Treagus, Executive Chairman, expressed his delight in the partnership and highlighted the strong complementary fit between the Wexler range and BTC's expanding cardiothoracic product portfolio. This agreement aligns with BTC's focus on providing access to specialized therapeutics and medical devices, furthering its goal of building a group of high-growth businesses focused on innovative medical products in the region.